IBIS LABS
·
Company Introduction · 2026
Platforms that turn scientific evidence into persistent, measurable HCP engagement.
Publishers produce rigorous, peer-reviewed evidence. Pharma teams need to deliver it to the right HCPs — compliantly, and with measurable impact.
But in practice, it breaks down:
PDFs in email. Dead links. Fragile workflows.
Analytics that stop at a page view.
A unified system — from content control to evidence engagement.
A controlled environment where licensed evidence, summaries, and claims are organized, governed, and delivered in context.
Designed to support compliant review, structured narratives, and measurable engagement across campaigns and congresses.
Supports the full spectrum of scientific evidence — from full-text publications to approved summaries, multimedia, and interactive assets.
Structured access to licensed evidence, summaries, and insights —organized for real clinical context.
Every event is timestamped and attributable — capturing how evidence is accessed, explored, and engaged. Enough detail for MLR review — not a byte more than necessary.
This level of visibility supports internal review — and can be extended into downstream systems to inform broader engagement strategies.
See what’s working, where attention drops, and what’s driving engagement. AI surfaces patterns and outliers — instantly.
A scalable model for delivering, measuring, and extending evidence engagement across client programs.
A repeatable model that takes evidence from curation to measurable impact — built in weeks, not months.
Reference: 2026 SITC Oncology Evidence Hub (sample program data)
Engagement data doesn’t stop at reporting.
Connect engagement insight to downstream systems, so what’s learned can inform what happens next.
MedEngage supports compliant integration with CRM and field platforms, enabling visibility into engagement patterns at both the account and HCP level.
Designed to inform engagement — not dictate it.
From content control to engagement to activation.
Bring a congress, launch, or pipeline asset.
We’ll scope a pilot, curate the evidence, and get you live — fast.